⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNTX News
Context Therapeutics Inc. Common Stock
Form 8-K
sec.gov
CNTX
Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
businesswire.com
NEOG
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
globenewswire.com
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
globenewswire.com
CNTX
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
globenewswire.com
CNTX
Form 8-K
sec.gov
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
CNTX